PB2376: ASSAY DEVELOPMENT AND VALIDATION OF IG-HTS TO MONITOR MRD IN PLASMA OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Jinghua Wu,
LI-Jie Xing,
Fan Yang,
Xiaoxia Wang,
Shixin Lu,
Shunjin Zhang,
Sen Yin,
Hai-Chen Wei,
Zengjun LI,
Xiao Liu
Affiliations
Jinghua Wu
1 NeoImmune Co., Ltd., Shenzhen, China
LI-Jie Xing
2 Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences, Department of Lymphoma and Hematology, Jinan, China
Fan Yang
1 NeoImmune Co., Ltd., Shenzhen, China
Xiaoxia Wang
1 NeoImmune Co., Ltd., Shenzhen, China
Shixin Lu
1 NeoImmune Co., Ltd., Shenzhen, China
Shunjin Zhang
1 NeoImmune Co., Ltd., Shenzhen, China
Sen Yin
1 NeoImmune Co., Ltd., Shenzhen, China
Hai-Chen Wei
2 Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences, Department of Lymphoma and Hematology, Jinan, China
Zengjun LI
2 Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences, Department of Lymphoma and Hematology, Jinan, China
Xiao Liu
3 Shenzhen International Graduate School, Tsinghua University, Shenzhen, China
